In compliance with this result, clinical breast cancer samples analysis confirmed that IL-6R expression was significantly associated with tamoxifen resistance in breast cancer tissues, with high IL-6R expression correlated with poor survival (113). This evidence concerns the gene IL6R and breast carcinoma.